Biotech

Cerecor Announces Development Advisory Board

BALTIMORE, MD: ...

Mnemosyne Pharmaceuticals, Inc. Completes $5.4 Million Series A Round to Support Drug Discovery Programs

PROVIDENCE, RI: ...

West Announces Fourth Quarter 2011 Results, Provides 2012 Guidance

LIONVILLE, PA: Conference Call Scheduled for 9 a.m. Today ...

Sunshine Heart Announces NASDAQ Listing

SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN: Shares to Begin Trading Under the Symbol 'SSH' ...

With Final Review of Phase IIb Viral Load Data Completed, Researchers Confirm Statistically Significant Reduction of HIV Viral Load on Vacc-4x Compared to Placebo

OSLO, NORWAY: Bionor's Clinical Research Program Moves Forward With Three Main Pathways to Market ...

Biota Announces Financial Results for First Half of Fiscal 2012

MELBOURNE, AUSTRALIA: BARDA Contract Well on Track and Full Phase 2b Results of Human Rhinovirus Study Expected in First Half of Calendar 2012 ...

Critical Outcome Technologies Inc. to Deliver Scientific Podium Presentation on COTI-2

LONDON, ONTARIO: ...

Miraculins Appoints Distinguished U.S. Cardiologist Dr. Henry Solomon to PreVu Medical Advisory Board

WINNIPEG, MANITOBA: Former Chief Medical Officer of the American College of Cardiology to Advise on U.S. Launch Strategy ...

Marina Biotech Announces Closure of Cambridge Site and Consolidation of R&D Operations in Bothell, WA

BOTHELL, WA: Company Initiates Dosing in the First Patient in Cohort 2 of the START-FAP Clinical Trial ...

Phase 3 Data on HEPLISAV(TM) in Adults Aged 18-55 Published in VACCINE

BERKELEY, CA: ...